Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.4.0.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating costs and expenses:    
Research and development $ (429,281) $ (1,035,083)
General and administrative (1,422,366) (935,226)
Loss from operations (1,851,647) (1,970,309)
Other income (expense):    
Change in fair value of derviative liability 136,014 0
Loss on issuance of hybrid debt instrument (1,584,218) 0
Other expense (26,414) (459,968)
Interest income 14 174
Interest expense (245,384) (1,126)
Total other income (expense) (1,719,988) (460,920)
Net loss (3,571,635) (2,431,229)
Other comprehensive loss from foreign currency translation adjustment 0 11,821
Total comprehensive loss $ (3,571,635) $ (2,419,408)